What is Alnylam Pharmaceuticals's shares (basic)?

Alnylam Pharmaceuticals (ALNY) reported shares (basic) of 132.9M in Q1 2026.

How has Alnylam Pharmaceuticals's shares (basic) changed year-over-year?

Alnylam Pharmaceuticals's shares (basic) increased by 2.5% year-over-year, from 129.7M to 132.9M.

What does shares (basic) mean?

The average number of actual shares owned by investors throughout the year, accounting for any shares the company bought back or issued.

Earnings Per Share

Shares (Basic)

Alnylam Pharmaceuticals Shares (Basic) increased by 1.1% to 132.9M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.5%, from 129.7M to 132.9M.

Analysis

StatementIncome Statement

SectionEarnings Per Share

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ4 2013

Last reportedQ4 2025

How to read this metric

A decreasing trend typically signals an aggressive share buyback program, which can increase the value of remaining shares.

Detailed definition

Weighted-average shares outstanding (basic) is the calculation of the total number of common shares held by the public d...

Peer comparison

Used to evaluate the scale of a company's equity base relative to its market capitalization and peer group.

Metric ID: weighted_shares_basic

Historical Data

15 periods

	Q2 '21	Q3 '21	Q1 '22	Q2 '22	Q3 '22	Q1 '23	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	117.8M	119.1M	120.4M	120.9M	122.2M	124.1M	124.7M	125.2M	126.1M	126.7M	128.6M	129.7M	130.6M	131.4M	132.9M
QoQ Change	—	+1.2%	+1.1%	+0.4%	+1.1%	+1.6%	+0.4%	+0.5%	+0.7%	+0.5%	+1.5%	+0.8%	+0.7%	+0.6%	+1.1%
YoY Change	—	—	—	+2.7%	+2.5%	+3.1%	+3.1%	+2.5%	+1.6%	+1.7%	+2.7%	+2.8%	+3.1%	+2.2%	+2.5%

Range117.8M – 132.9M

CAGR+3.5%

Avg YoY Growth+2.5%

Median YoY Growth+2.6%

Current Streak14+ quarters growth

Shares (Basic) at Other Companies

Agilent TechnologiesA View metric

AmgenAMGN View metric

Regeneron PharmaceuticalsREGN View metric

AbbVieABBV View metric

Gilead SciencesGILD View metric

PfizerPFE View metric

Frequently Asked Questions

What is Alnylam Pharmaceuticals's shares (basic)?: Alnylam Pharmaceuticals (ALNY) reported shares (basic) of 132.9M in Q1 2026.
How has Alnylam Pharmaceuticals's shares (basic) changed year-over-year?: Alnylam Pharmaceuticals's shares (basic) increased by 2.5% year-over-year, from 129.7M to 132.9M.
What does shares (basic) mean?: The average number of actual shares owned by investors throughout the year, accounting for any shares the company bought back or issued.